Abstract
Bromocriptine combined with galactose restriction in the matenal diet seems to be partially effective in decreasing endogenous lactose and galactose synthesis, monitored in a pregnant woman heterozygous for galactosaemia at risk of producing a homozygous infant.
MeSH terms
-
Bromocriptine / therapeutic use*
-
Diet
-
Female
-
Galactose / administration & dosage
-
Galactose / biosynthesis*
-
Galactosemias / drug therapy
-
Galactosemias / genetics*
-
Heterozygote*
-
Humans
-
Lactose / biosynthesis*
-
Pregnancy
-
Pregnancy Complications*
Substances
-
Bromocriptine
-
Lactose
-
Galactose